Cavosonstat

Basic Information

CAS ID: 1371587-51-7
Molecular Formula: C16H10ClNO3
Molecular Weight: 299.7 g/mol
Monoisotopic Mass: 299.0349 g/mol
Class: Small Molecule
Natural Product: No
Other Names: N91115 | CAVOSONSTAT
Analysis: Drug repositioning mechanism analysis

OH O Cl OH N

Compound Structure and Identifier

InChI: InChI=1S/C16H10ClNO3/c17-13-8-10(16(20)21)1-4-12(13)15-5-2-9-7-11(19)3-6-14(9)18-15/h1-8,19H,(H,20,21) See All
InChI Key: BXSZILNGNMDGSL-UHFFFAOYSA-N
Smiles: OC(=O)c1ccc(c(Cl)c1)c2ccc3cc(O)ccc3n2 See All
Molfile: Download

Related Target

Related Fibrosis Property

Trial Record 1

ClinicalTrial ID NCT02227888 Disease Cystic fibrosis
Phase Phase 1 Status Completed
First Received August 28, 2014 Last Verified November 7, 2016
Sponsor Nivalis Therapeutics, Inc.

Trial Record 2

ClinicalTrial ID NCT02275936 Disease Cystic fibrosis
Phase Phase 1 Status Completed
First Received October 27, 2014 Last Verified November 7, 2016
Sponsor Nivalis Therapeutics, Inc.

Trial Record 3

ClinicalTrial ID NCT02589236 Disease Cystic fibrosis
Phase Phase 2 Status Completed
First Received October 28, 2015 Last Verified January 10, 2017
Sponsor Nivalis Therapeutics, Inc.

Trial Record 4

ClinicalTrial ID NCT02724527 Disease Cystic fibrosis
Phase Phase 2 Status Unknown
First Received March 31, 2016 Last Verified November 21, 2016
Sponsor Nivalis Therapeutics, Inc.

Trial Record 5

ClinicalTrial ID NCT02934139 Disease Cystic fibrosis
Phase Phase 1 Status Completed
First Received October 14, 2016 Last Verified January 31, 2017
Sponsor Nivalis Therapeutics, Inc.

Related Link

PubChem: 56960912
ChEMBL: CHEMBL3989910